Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROSE: Dopamine and Nesiritide in Acute Heart Failure
NCT01132846Phase 2Completed
- Sponsor
- Duke University
- Start
- Aug 2010
- Primary completion
- May 2013
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of dopamine, nesiritide in Acute Heart Failure (AHF), sponsored by Duke University. Started Aug 2010; status: completed.
02
Drugs
dopaminenesiritide
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT01132846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01132846.